CAMBRIDGE, Mass.--Cubist Pharmaceutical Inc. here has taken a $1 million minority position in Novalon Pharmaceutical Corp. and will provide the Chapel Hill, N.C., startup with research support, including bioinformatics help. Cubist also gained a six-month option to acquire all outstanding shares of Novalon. An internet search led to the match.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.